<?xml version="1.0" encoding="UTF-8"?>
<ref id="r120">
 <label>120</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Serafin</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Foco</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Zanigni</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Blankenburg</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Picard</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Zanon</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Giannini</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Pichler</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Facheris</surname>
    <given-names>MF</given-names>
   </name>
   <name>
    <surname>Cortelli</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Pramstaller</surname>
    <given-names>PP</given-names>
   </name>
   <name>
    <surname>Hicks</surname>
    <given-names>AA</given-names>
   </name>
   <name>
    <surname>Domingues</surname>
    <given-names>FS</given-names>
   </name>
   <name>
    <surname>Schwienbacher</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <year>2015</year>
  <article-title>Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD</article-title>
  <source>Neurology</source>
  <volume>84</volume>
  <fpage>645</fpage>
  <lpage>653</lpage>
  <pub-id pub-id-type="pmid">25596505</pub-id>
 </element-citation>
</ref>
